Middle East And Africa Bispecific Antibodies Market Size & Outlook, 2025-2031
Middle East And Africa Bispecific Antibodies Market Size
According to Straits Research analysis, the Middle East And Africa Bispecific Antibodies Market was valued at USD 456.79 Million in 2024 and is projected to reach USD 1420.58 Million by 2031, expanding at a CAGR of 18.5% during the forecast period. This growth is primarily driven by rising investment in healthcare and increased incidence of chronic diseases like cancer. In addition, the development of innovative biotherapeutic drugs is supporting the market growth. Industry-specific use cases include research in oncology and autoimmune diseases. Emerging advancements in biopharmaceuticals and genetic engineering provide further growth opportunities. Moreover, the potential for export to worldwide markets where bispecific antibodies are in high demand is also a significant contributor to market growth allowing the region to position itself lucratively in the global market. The Middle East and Africa are, therefore, paving a strong path in the bispecific antibodies market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Bispecific Antibodies Market Highlights
- By market size, Bi-specific T-cell engager led the Type category in 2024.
- The Type segment led by Bi-specific T-cell engager is estimated to post the fastest growth, sustaining its position as the most lucrative during the forecast timeframe.
- Middle East And Africa represented 8.29% of the global bispecific antibodies market size in 2024.
- By 2031, United States is estimated to hold the largest position in the global market in terms of size.
- South Africa is estimated to remain the fastest-growing market in Middle East And Africa, advancing to USD 25.81 Million by 2031.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2031 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2031 |
| Market Size In 2024 | USD 456.79 Million |
| Market Size In 2031 | USD 1420.58 Million |
| Largest segment | Bi-specific T-cell engager |
| Fastest segment | Bi-specific T-cell engager |
| Units | Revenue in USD Million |
| CAGR | 18.5% (2025-2031) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Middle East And Africa Bispecific Antibodies Market Share By Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Country |
|
| Type |
|
| Therapeutic Areas |
|
| Target |
|
Middle East And Africa Bispecific Antibodies Market By Country 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Bispecific Antibodies Market By Type 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Bispecific Antibodies Market By Therapeutic Areas 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Bispecific Antibodies Market By Target 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
